ATC code None PubChem CID 11539381 Formula C20H18F3N3O3S | Legal status Investigational ChemSpider 9714160 Molar mass 437.435 | |
 | ||
MBX-8025 is a PPARδ receptor agonist that is being investigated for drug use by Metabolex. According to a press release they are examining its potential use for the treatment of dyslipidemia, metabolic syndrome, type 2 diabetes, and non-alcoholic steatohepatitis (NASH). The compound, formerly known as RWJ-800025, was licensed from Janssen Pharmaceutica NV.
References
MBX-8025 Wikipedia(Text) CC BY-SA